Pharmacological Interventions for Treatment of Sarcopenia: Current Status of Drug Development for Sarcopenia
Sarcopenia, the loss of skeletal muscle mass and function with age, was first recognized as a disease in the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) (M62.84) and has recently attracted attention as aged populations increase. However, the diagnostic...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korea Geriatrics Society
2019-09-01
|
Series: | Annals of Geriatric Medicine and Research |
Subjects: | |
Online Access: | http://www.e-agmr.org/upload/pdf/agmr-19-0028.pdf |